BioSpace News Archive

Digital Alpha, a leading digital infrastructure investment firm, and Sharecare, the digital health company that helps people manage all their health in one place, today announced the initiation of a strategic collaboration to accelerate their shared vision to improve the economic health of communities and the well-being of their citizens

Novamind Inc., a mental health company specialized in psychedelic medicine, announces that its common shares, previously listed for trading on the OTC Pink Market in the United States under the symbol “HNLMF”, are to commence trading on the OTC Pink Market under the symbol “NVMDF” effective February 19, 2021.

AbbVie (NYSE: ABBV), Evolus (NASDAQ: EOLS) and Medytox announce settlement agreements to fully resolve all outstanding litigation, including the United States International Trade Commission (ITC) case regarding the sale of Jeuveau®, between the companies.

Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, today announced that it has entered into a definitive agreement for the sale of its equity securities in a private placement to institutional investors, including Redmile Group and SIO Capital Management.

There have been multiple incidents of acetaminophen poisoning in young children due to unintentional exposure to adult acetaminophen easy-to-swallow tablets. Acetaminophen overdose poses a high risk of liver damage.

Results published today in the Journal of Psychopharmacology, show that MDMA-Assisted Psychotherapy (3,4-methylenedioxymethamphetamine) was well tolerated by all participants.

The North America dermal filler market is anticipated to garner a revenue worth more than $3 billion by 2026.

An elevating patient pool in the economies of North America, driven by a large geriatric population may fuel the growth of North America emergency medical supplies market over the time period of 2020-2026.

The North America esoteric testing market is expected to record appreciable growth over the ensuing years, on the back of increasing awareness regarding early diagnosis of rare diseases.

The soaring growth pace of the North America gene editing market is rather evident with the invention of a new CRISPR gene editing technology that enables the detection of the Sars-CoV-2 or COVID-19.